Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patients (Q32014650)

5 July 2017

title

Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patients (English)

1 reference

5 July 2017

1 reference

1 reference

1 reference

9

G Giaccone

1 reference

5 July 2017

J M van Riel

1

1 reference

5 July 2017

C J van Groeningen

2

1 reference

5 July 2017

S H Albers

3

1 reference

5 July 2017

M Cazemier

4

1 reference

5 July 2017

S Meijer

5

1 reference

5 July 2017

R Bleichrodt

6

1 reference

5 July 2017

F G van den Berg

7

1 reference

5 July 2017

H M Pinedo

8

1 reference

5 July 2017

language of work or name

1 reference

1 December 2000

1 reference

5 July 2017

1 reference

5 July 2017

volume

11

1 reference

5 July 2017

issue

12

1 reference

5 July 2017

page(s)

1563-1570

1 reference

Factors influencing the natural history of colorectal liver metastases

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Randomized trial of hepatic arterial floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Regional chemotherapy devices: effect of experience and anatomy on complications

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Hepatic arterial infusion chemotherapy using percutaneous catheter placement with an implantable port: assessment of factors affecting patency of the hepatic artery

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008369520179

7 January 2021

Identifiers

DOI

10.1023/A:1008369520179

1 reference

release_ouiqejml6ja3vlr6irtsakp3bu

5 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ouiqejml6ja3vlr6irtsakp3bu

24 November 2022

mapped directly with Wikidata item

1 reference